In a move poised to redefine Brazil’s global commodities trade, SMX (Security Matters) (NASDAQ:SMX) Ltd. and Ybyrá Capital S.A. are inching closer to finalizing a game-changing partnership. Announced ...

MIAMI, FL / ACCESS Newswire / January 27, 2025 / In a move poised to redefine Brazil's global commodities trade, SMX (Security Matters) (NASDAQ:SMX) Ltd. and Ybyrá Capital S.A. are inching closer to f ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

A new stretchable organic solar cell may offer the efficient power source needed for the next generation of wearable devices.

SMX PLC (NASDAQ:SMX)(NASDAQ:SMXWW) is solidifying its position as a pivotal partner in developing digital solutions that drive and manage a global circular economy. At the forefront of these efforts ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

AbbVie and Neomorph are set to enter a partnership and option-to-license agreement to develop molecular glue degraders.

Antonina Mitrofanova, an associate professor in the Department of Health Informatics and associate dean for research at the Rutgers School of Health Professions, has been awarded the Presidential ...

Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platform Neomorph to receive ...